Dow Jones

39 118,86

-0,12%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Biotech Acquisition Company (BIOTU)
Biotech Acquisition Company (BIOTU) Actualités

BIOTU

Biotech Acquisition (BIOTU)

Biotech Acquisition Company

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:BIOTU

Date	Heure	Source	Titre	Symbole	Société
14/02/2023	23h02	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:BIOTU	Biotech Acquisition Company
13/02/2023	20h12	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BIOTU	Biotech Acquisition Company
02/02/2023	22h56	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:BIOTU	Biotech Acquisition Company
02/02/2023	12h04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOTU	Biotech Acquisition Company
02/02/2023	01h50	GlobeNewswire Inc.	Biotech Acquisition Company Announces Liquidation	NASDAQ:BIOTU	Biotech Acquisition Company
27/01/2023	19h19	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BIOTU	Biotech Acquisition Company
04/01/2023	21h20	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BIOTU	Biotech Acquisition Company
22/11/2022	12h05	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOTU	Biotech Acquisition Company
14/11/2022	19h44	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:BIOTU	Biotech Acquisition Company
17/06/2022	22h06	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	NASDAQ:BIOTU	Biotech Acquisition Company
03/06/2022	12h03	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOTU	Biotech Acquisition Company
10/05/2022	12h08	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BIOTU	Biotech Acquisition Company
09/05/2022	23h26	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:BIOTU	Biotech Acquisition Company
18/04/2022	12h05	Edgar (US Regulatory)	Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)	NASDAQ:BIOTU	Biotech Acquisition Company
16/03/2022	13h00	PR Newswire (US)	Biotech Acquisition Company Announces Public Filing of Registration Statement on Form S-4 Related to Proposed Merger with Blade Therapeutics, Inc.	NASDAQ:BIOTU	Biotech Acquisition Company
15/03/2022	21h44	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:BIOTU	Biotech Acquisition Company
08/03/2022	12h04	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BIOTU	Biotech Acquisition Company
08/03/2022	12h01	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:BIOTU	Biotech Acquisition Company
15/03/2021	13h00	PR Newswire (US)	Biotech Acquisition Company Announces Separate Trading of its Class A Ordinary Shares and Warrants Commencing March 18, 2021	NASDAQ:BIOTU	Biotech Acquisition Company
28/01/2021	20h58	GlobeNewswire Inc.	Biotech Acquisition Company Announces Closing of $230,000,000 Initial Public Offering	NASDAQ:BIOTU	Biotech Acquisition Company
26/01/2021	02h47	GlobeNewswire Inc.	Biotech Acquisition Company Announces Pricing of $200 Million Initial Public Offering	NASDAQ:BIOTU	Biotech Acquisition Company